Novel inhibitors of human immunodeficiency virus type 2 infectivity

Human immunodeficiency virus type 2 (HIV-2) infects about two million people worldwide. HIV-2 has fewer treatment options than HIV-1, yet may evolve drug resistance more quickly. We have analysed several novel drugs for anti-HIV-2 activity. It was observed that 5-azacytidine, clofarabine, gemcitabin...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Gen Virol
Auteurs principaux: Beach, Lauren B., Rawson, Jonathan M., Kim, Baek, Patterson, Steven E., Mansky, Louis M.
Format: Artigo
Langue:Inglês
Publié: Society for General Microbiology 2014
Sujets:
Animal
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4233633/
https://ncbi.nlm.nih.gov/pubmed/25103850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1099/vir.0.069864-0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires